Organon’s steroid-free cream Vtama wins approval in atopic dermatitis

Organon won a label expansion on Friday for the steroid-free topical cream it picked up from its October acquisition of Dermavant.

Vtama, also known as …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Birch triterpenes by Chiesi Farmaceutici for Radiodermatitis: Likelihood of Approval

Birch triterpenes is under clinical development by Chiesi Farmaceutici and currently in Phase II for Radiodermatitis.

January 25, 2024

GSK reports Blenrep overall survival data in multiple myeloma as it plots market reentry

SAN DIEGO — Two years after pulling Blenrep from the market, GSK is positioning for a relaunch. This time, the company says it’s coming from

December 10, 2024

Rejuvenation Startup Summit 2024 announces first set of speakers – Biotech Investments

EQS-News: Forever Healthy Foundation gGmbH / Key word(s): Conference Rejuvenation Startup Summit 2024 announces first set of speakers 08.11.2023 / 10:00 CET/CEST The issuer is

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.